Exploring Applications of In Silico Screening to Enable Faster & More Precise Antigen Epitope Discovery for Cancer Vaccine Therapies

• Utilizing in silico screening tools to enable faster and more precise antigen and drug discovery
• Leveraging in silico screening platforms to discover antigen epitopes for cancer vaccine therapies, validated with preclinical performance of clinical-stage pipeline
• Laying out development of novel mRNA-based cancer vaccines with antigen epitopes derived through in silico screening 

Speakers:

Wonil Kim

Chief Scientific Officer

Aston Sci